Action Items
Helix Instruments · delegate, govern, and sign off — the work queue the agent is driving to the number.
ACT · delegate / govern
Pilot
LIVEData as of 29 May 2026, 16:42 · last feed run 11 min ago
Handled autonomously4
- Auto-fixed stale next-step on Borealis Sensing D — expansion
- Auto-fixed stale next-step on Cyto Analytics C — new
- Auto-fixed stale next-step on Vanta Labs C — expansion
- Auto-fixed stale next-step on Probe Therapeutics A — expansion
Low-risk CRM hygiene — applied and logged, not asked.
Waiting on you18
18 draft-only items need a human commit.
Every email, request, assignment, approval, and the forecast submission stays draft-only until you act — the agent recommends, you commit.
Forecast sign-off · dual control
Lock $811.0M as the plan of record. Maker-checker-approver — the submitter can’t approve their own.
12 actions in flight, working $0 of the $24.0M controllable gap.
Assign re-mix review — Quantix Sensing B — renewalqueued
taskowner Mia Rossi→ Ethan Moreaudue 08-07 Quantix Sensing B — renewal
Forecast Agent — pipeline analysis · win-rate re-weight · 89%CRM — open pipeline
+$0 gapEscalate at-risk deal — Axion Biosciences C — channelassigned
escalationowner Zoe Satodue 10-09 Axion Biosciences C — channel
Forecast Agent — pipeline analysis · win-rate re-weight · 86%CRM — open pipeline
+$0 gapCommit downside scenario as plan of recordin-progress
scenarioowner Ethan Moreaudue 11-10 Cyto Analytics D — new
Forecast Agent — pipeline analysis · win-rate re-weight · 64%CRM — open pipeline
+$0 gapAssign re-mix review — Lumen Analytics F — expansionin-review
taskowner Sven Bergström→ Hana Vancedue 09-14 Lumen Analytics F — expansion
Forecast Agent — pipeline analysis · win-rate re-weight · 61%CRM — open pipeline
+$0 gapApprove forecast submissionqueued
approvalowner Yuki Okafordue 10-15 Quantix Sensing A — channel
Forecast Agent — pipeline analysis · win-rate re-weight · 70%CRM — open pipeline
+$0 gapCommit downside scenario as plan of recordassigned
scenarioowner Hana Vancedue 06-17 Axion Biosciences B — expansion
Forecast Agent — pipeline analysis · win-rate re-weight · 91%CRM — open pipeline
+$0 gapAssign re-mix review — Helios Biosciences E — expansiondrafted
taskowner Ingrid Diaz→ Felix Kimdue 10-21 Helios Biosciences E — expansion
Forecast Agent — pipeline analysis · win-rate re-weight · 85%CRM — open pipeline
+$0 gapApprove forecast submissionin-review
approvalowner Theo Lindqvistdue 11-22 Orbital Instruments — channel
Forecast Agent — pipeline analysis · win-rate re-weight · 66%CRM — open pipeline
+$0 gapEscalate at-risk deal — Pinnacle Research — expansionqueued
escalationowner Nadia Kowalskidue 06-23 Pinnacle Research — expansion
Forecast Agent — pipeline analysis · win-rate re-weight · 72%CRM — open pipeline
+$0 gapApprove forecast submissiondrafted
approvalowner Ava Castellanodue 06-09 Vector Labs E — renewal
Forecast Agent — pipeline analysis · win-rate re-weight · 79%CRM — open pipeline
+$0 gapEscalate at-risk deal — Orbital Instruments F — channelin-review
escalationowner Liam Andersendue 07-10 Orbital Instruments F — channel
Forecast Agent — pipeline analysis · win-rate re-weight · 85%CRM — open pipeline
+$0 gapCommit downside scenario as plan of recordqueued
scenarioowner Mia Rossidue 08-11 Pinnacle Research F — expansion
Forecast Agent — pipeline analysis · win-rate re-weight · 74%CRM — open pipeline
+$0 gapApprove forecast submissionsent
approvalowner Noah Reyesdue 09-08 Cobalt Materials B — renewal
Forecast Agent — pipeline analysis · win-rate re-weight · 88%CRM — open pipeline
+$0 gapEscalate at-risk deal — Cobalt Materials A — expansionsent
escalationowner Diego Ferreiradue 11-16 Cobalt Materials A — expansion
Forecast Agent — pipeline analysis · win-rate re-weight · 91%CRM — open pipeline
+$0 gapCommit downside scenario as plan of recordsent
scenarioowner Felix Kimdue 07-24 Probe Therapeutics B — new
Forecast Agent — pipeline analysis · win-rate re-weight · 64%CRM — open pipeline
+$0 gapAssign re-mix review — Strata Therapeutics D — newdismissed
taskowner Kenji Nakamura→ Mia Rossidue 11-08 Strata Therapeutics D — new
Forecast Agent — pipeline analysis · win-rate re-weight · 71%CRM — open pipeline
+$0 gapDismissed — Owner confirmed deal still on track